捷安高科:2025一季报净利润-0.07亿 同比下降40%

Financial Performance - The company reported a basic earnings per share of -0.0500 yuan for Q1 2025, a decrease of 25% compared to -0.0400 yuan in Q1 2024 and an improvement from -0.0600 yuan in Q1 2023 [1] - The net profit for Q1 2025 was -0.07 billion yuan, representing a 40% decline from -0.05 billion yuan in Q1 2024 and a slight improvement from -0.06 billion yuan in Q1 2023 [1] - The company's total revenue for Q1 2025 was 0.25 billion yuan, showing a 4.17% increase from 0.24 billion yuan in Q1 2024 and an increase from 0.23 billion yuan in Q1 2023 [1] - The return on equity (ROE) was -0.82% in Q1 2025, down 38.98% from -0.59% in Q1 2024, and slightly improved from -0.81% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 30.17 million shares, accounting for 29.49% of the circulating shares, with a change of 28,600 shares from the previous period [1] - Notable shareholders include Yong'an Jiajing Enterprise Management Partnership (holding 8.88% of total shares), Zheng Leguan (5.31%), and Zhang Anquan (5.09%), all of whom maintained their holdings [2] - New entrants to the top ten shareholders include Barclays Bank PLC (0.89%), Goldman Sachs LLC (0.69%), and Ding Riheng (0.48%) [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares in the current period [2]